Episode Description
The unprecedented nature of the Food and Drug Administration's approval of Alzheimer’s drug Aduhelm has led to more negative publicity than perhaps any other new medication, at least in recent years. Wayne Pines, former FDA official and now president of healthcare at APCO, joins Marc Iskowitz to discuss the implications for the agency’s role in advising pharma companies and other ripple effects involving communication.
Check us out at: mmm-online.com
Follow us:
YouTube: @MMM-online
TikTok: @MMMnews
Instagram: @MMMnewsonline
Twitter/X: @MMMnews
LinkedIn: MM+M
To read more of the most timely, balanced and original reporting in medical marketing, subscribe here.
Music: “Deep Reflection” by DP and Triple Scoop Music.
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
Listen On
